Can Prostate Specific Antigen Velocity Thresholds Decrease Insignificant Prostate Cancer Detection?

A prostate specific antigen velocity threshold of 0.4 ng/ml per year was associated with the likelihood of insignificant prostate cancer. This suggests that prostate specific antigen velocity may be a useful adjunct in prostate cancer screening to increase specificity for identifying patients with clinically significant disease.